Evidence map›Paper›PMID 42168441›Full record

ArticleScientific reports2026

Exploring the functional and immunological diversity of the fatty acid-binding protein (FABP) family in Fasciola hepatica.

Alicja Kalinowska, Mateusz Pękacz, Katarzyna Basałaj, Alicja Laskowska, Agnieszka Wesołowska, Daniel Młocicki, Bruno Guigas, Anna Zawistowska-Deniziak

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alicja KalinowskaMuseum and Institute of Zoology PAS, Twarda 51/55, 00-818, Warsaw, Poland.
Mateusz PękaczPathogen Immunobiology Group, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Katarzyna BasałajPathogen Immunobiology Group, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Alicja LaskowskaPathogen Immunobiology Group, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Agnieszka WesołowskaMuseum and Institute of Zoology PAS, Twarda 51/55, 00-818, Warsaw, Poland.
Daniel MłocickiDepartment of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland.
Bruno GuigasLeiden University Center for Infectious Diseases, Subdepartment Research, Systemic Immunometabolism Group, Leiden University Medical Center, Leiden, The Netherlands.
Anna Zawistowska-DeniziakPathogen Immunobiology Group, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, Warsaw, Poland. a.zawistowska-deniziak@uw.edu.pl.

Funding

Narodowe Centrum Nauki SONATA 2021/43/D/NZ6/01555
6 · The paper itself

Abstract

The liver flukes Fasciola hepatica and Fasciola gigantica cause fasciolosis, a zoonotic disease of major health and livestock importance. To evade host immunity, these parasites secrete immunomodulatory molecules, including fatty acid-binding proteins (FABPs), which are essential for parasite survival by mediating fatty acid uptake and transport, and by exerting anti-inflammatory effects that promote immune evasion and chronic infection. This study investigates the roles of F. hepatica FABPs' in nutrient acquisition, immune modulation, and parasite survival, assessing their potential as vaccine, diagnostic, and therapeutic targets. We cloned all seven FhFABP isoforms and expressed six recombinantly in yeast. Gene expression analysis showed stage-specific patterns, with the highest levels in adult flukes. Isoform-specific analysis further highlighted stage-dependent expression dynamics, and functional characterization revealed distinct fatty acid-binding properties, suggesting adaptive roles in parasite survival. We assessed IgG responses in infected sheep, finding peak titer against FhFABP5 at 6-8 weeks post-infection (WPI) and a strong, prolonged response to FhFABP4, lasting 6-12 weeks. These results highlight FhFABPs as immunogenic targets for diagnostics or vaccines. Additionally, FhFABPs differentially modulated the activity of human monocyte-derived dendritic cells. Our findings emphasize the multifaceted roles of FhFABPs in nutrient acquisition and immune modulation, underscoring their potential as targets for vaccines, diagnostics, and anti-inflammatory therapies.

Indexed as

Fasciola hepaticaFascioliasisFatty Acid-Binding ProteinsHelminth ProteinsAnimalsAntibodies, HelminthCloning, MolecularImmunoglobulin GProtein IsoformsSheepSheep DiseasesAntibodies, HelminthFatty Acid-Binding ProteinsHelminth ProteinsImmunoglobulin GProtein IsoformsFasciola hepaticaFatty acid-binding proteinFunctional characterizationGene expressionImmunological characterization

Identifiers

PMID42168441
PMCPMC13396458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.